脂质体
聚乙二醇化
体内分布
阿霉素
药代动力学
药理学
心脏毒性
医学
小泡
药品
磷脂
药物输送
毒品携带者
毒性
生物物理学
化学
膜
生物化学
化疗
体外
内科学
生物
聚乙二醇
有机化学
作者
Christine E. Swenson,Walter R. Perkins,Patricia J. Roberts,Andrew S. Janoff
出处
期刊:The Breast
[Elsevier]
日期:2001-06-01
卷期号:10: 1-7
被引量:112
标识
DOI:10.1016/s0960-9776(01)80001-1
摘要
Liposomes are phospholipid membrane vesicles that can act as carriers for drugsin order to target them to specific tissues. Encapsulation within a liposome can confer benefits such as longer circulation times, higher stability and reduced toxicity due to targeting of the active drug. Important features that can alter the biodistribution or pharmacokinetics of loaded liposomes include the liposome size, lipid-to-drug ratio, surface characterization (e.g. pegylation) and the method of loading. Myocet was developed in order to target doxorubicin to tumour sites while sparing healthy tissues; in particular the heart. The Myocet loading technique involves a pH gradient and a citrate complex, which allows a very high drug-to-lipid ratioand the use of small liposomes that can accumulate in the tumour through the leaky vasculature that supplies them. Preclinical studies indicate that Myocet accumulation in tumour tissue is more persistent and pervasive than that of conventional doxorubicin. In addition, Myocet is targeted away from the heart, leading to reduced cardiotoxicity without compromising antitumour efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI